NeuroVigil, a San Diego, CA-based neurotechnology company, closed its first round of financing.
The round was led by an anonymous investor, with participants distributed across both the U.S. West and East Coasts including First Round Capital’s Dr. Howard Morgan, and Mr. Alexis Flint.
Founded by Chairman and CEO Dr. Philip Low, NeuroVigil created the iBrainTM device, which allows pharmaceutical companies and research institutions to collect brainwave activity from patients at home instead of in the hospital use.
The company, which owns the devices and the data, is searching for biomarkers of major neuropathologies as well as potential signatures of pre-market drugs on the brain.
FinSMEs
03/05/2011